Related Experiment Video
Updated: Jul 19, 2025

On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
The genesis of cardiovascular risk in inflammatory arthritis: insights into glycocalyx shedding, endothelial
Alexander Krasimirov Angelov1,2, Miroslav Markov3,4, Mariana Ivanova1,2
1Medical Faculty, Medical University - Sofia, Sofia, 1431, Bulgaria.
Insights
Inflammatory arthritis (IA) accelerates cardiovascular disease (CVD) by promoting atherosclerosis and endothelial dysfunction. The endothelial glycocalyx (EG) plays a key role in this process, highlighting the link between systemic inflammation and heart health.
Area of Science:
- Cardiovascular Pathology
- Rheumatology
- Immunology
Background:
- Inflammatory arthritis (IA) induces systemic inflammation beyond localized joint issues.
- Chronic inflammation in IA significantly accelerates cardiovascular disease (CVD) progression.
- The endothelial glycocalyx (EG) is implicated in early atherosclerosis development.
Purpose of the Study:
- To comprehensively review the interplay between IA and cardiovascular pathology.
- To elucidate the role of the endothelial glycocalyx (EG) in IA-driven CVD acceleration.
- To explore mechanisms linking inflammation, EG degradation, and endothelial dysfunction.
Main Methods:
- Narrative review of existing literature.
- Analysis of inflammatory mediators' impact on endothelial function and EG.
- Examination of microparticles, microRNA, and complement activation in CVD pathogenesis.
Main Results:
- IA exacerbates atherosclerosis initiation and endothelial dysfunction.
- Inflammatory mediators modulate microtubule dynamics, affecting EG integrity.
- Systemic inflammation and sheddases contribute to EG degradation, impacting CVD.
Conclusions:
- IA significantly accelerates CVD through systemic inflammation and EG damage.
- EG integrity is crucial for maintaining endothelial function in the context of IA.
- Understanding these mechanisms offers insights into preventing IA-related cardiovascular events.
Abstract:
This narrative review provides a comprehensive examination of the complex interplay between inflammatory arthritis (IA) and cardiovascular pathology. It particularly illuminates the roles of atherosclerosis initiation, endothelial dysfunction, and glycocalyx shedding. IA not only provokes tissue-specific inflammatory responses, but also engenders a considerable degree of non-specific systemic inflammation. This review underscores the accelerating influence of the chronic inflammatory milieu of IA on cardiovascular disease (CVD) progression. A focal point of our exploration is the critical function of the endothelial glycocalyx (EG) in this acceleration process, which possibly characterizes the earliest phases of atherosclerosis. We delve into the influence of inflammatory mediators on microtubule dynamics, EG modulation, immune cell migration and activation, and lipid dysregulation. We also illuminate the impact of microparticles and microRNA on endothelial function. Further, we elucidate the role of systemic inflammation and sheddases in EG degradation, the repercussions of complement activation, and the essential role of syndecans in preserving EG integrity. Our review provides insight into the complex and dynamic interface between systemic circulation and the endothelium.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation
Coronary Artery Disease I: Introduction
Inflammatory Response I: Vascular and Cellular
Rheumatic Heart Disease I: Introduction

